E83.821

Clinical Causes: Mutations in the ENPP1 gene, which is responsible for producing an enzyme called ectonucleotide pyrophosphatase/phosphodiesterase 1. Inheritance pattern generally follows an autosomal recessive trait, meaning a child needs to inherit the mutated gene from both parents. Genetic alterations lead to a deficiency or dysfunction of the ENPP1 enzyme, resulting in abnormal calcium and phosphate metabolism in the arteries.

Key Symptoms: Hardening and narrowing of arteries due to calcium deposits. High blood pressure resulting from arterial stiffness. Difficulty breathing or respiratory distress in severe cases. Potential for heart failure due to compromised blood flow. Poor growth or failure to thrive in infants. Claudication or limb pain in older children or adolescents as arterial deposits progress.

Diagnosis Path: Diagnosis of generalized arterial calcification of infancy linked to ENPP1 deficiency involves a combination of clinical assessments and specialized tests including: - Imaging studies such as X-rays, ultrasound, or CT scans to visualize arterial calcifications. - Blood tests to evaluate calcium and phosphate levels. - Genetic testing to identify mutations in the ENPP1 gene. - Family history assessment for inherited patterns of the disorder. Early diagnosis is crucial to manage the symptoms and prevent severe complications, although definitive diagnosis often relies on genetic confirmation.

Treatment Protocols: While there is no cure for ENPP1 deficiency-related arterial calcification, treatment focuses on managing symptoms and preventing complications: - Medications to control blood pressure, such as antihypertensives. - Dietary adjustments to regulate calcium and phosphate intake. - Use of phosphate binders to reduce serum phosphate levels. - Surgical interventions may be necessary to address severe arterial blockages or complications. - Regular monitoring through imaging and clinical evaluations to track disease progression. - Emerging therapies and clinical trials are ongoing to find targeted treatments for this genetic condition. Multidisciplinary care involving cardiologists, geneticists, and other specialists is vital for optimal management.